Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neural stem cell diversity and proteomics.
Fingolimod Therapy and Macular Hemorrhage.
The spectrum of post-vaccination inflammatory CNS demyelinating syndromes.
Helminth therapy or elimination: epidemiological, immunological, and clinical considerations.
Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness.
A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation procedures.
Inflammation high-field magnetic resonance imaging.
Is it useful to perform carbon monoxide diffusion capacity and respiratory muscle function tests in patients with multiple sclerosis without disability?
K(+) channel alterations in the progression of experimental autoimmune encephalomyelitis.
Delayed Central Nervous System Irradiation Effects in Rats - Part 2: Aggravation of Experimental Autoimmune Encephalomyelitis.
Resting-state connectivity of pre-motor cortex reflects disability in multiple sclerosis.
Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation.
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review.
Decoding Signaling and Function of the Orphan G Protein-Coupled Receptor GPR17 with a Small-Molecule Agonist.
Novel Immunomodulatory Approaches for the Management of Multiple Sclerosis.
Poster abstracts from the third international symposium on gait and balance in multiple sclerosis: selecting the right measures.
Discovery of Dual Leucine Zipper Kinase (DLK, MAP3K12) Inhibitors with Activity in Neurodegeneration Models.
Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial.
CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes.
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis.
Review of Animal Models of Neuromyelitis Optica.
Mobility and cognitive correlates of dual task cost of walking in persons with multiple sclerosis.
The pathogenic role of the inflammasome in neurodegenerative diseases.
High-Affinity Binding of Remyelinating Natural Autoantibodies to Myelin-Mimicking Lipid Bilayers Revealed by Nanohole Surface Plasmon Resonance.
Automatic Lesion Incidence Estimation and Detection in Multiple Sclerosis Using Multisequence Longitudinal MRI.
Pages
« first
‹ previous
…
271
272
273
274
275
276
277
278
279
…
next ›
last »